MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.125.046324

Медицинская библиотека · Journal of the American Heart Association · 2026

Impact of Perivascular Adipose Tissue Attenuation Around the Aortic Valve on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Okamoto Hiroya, Toba Takayoshi, Sugizaki Yoichiro, Kawamori Hiroyuki, Hiromasa Takashi, Fujimoto Daichi, Izawa Yu, Osumi Yuto, Yamamoto Tetsuya, Iwane Seigo, Naniwa Shota, Yoshida Chiaki, Sakamoto Yuki, Matsuhama Koshi, Fukuishi Yuta, Tsunamoto Hiroshi, Higuchi Kotaro, Watanabe Nobuhiro, Takata Ken, Iida Keisuke, Kitagawa Tatsuya, Masuda Mayuka, Yoshida Shotaro, Hashimura Hiromi, Murakami Takamichi, Otake Hiromasa

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Perivascular adipose tissue (PVAT) attenuation interacts with local and systemic vascular inflammation and consequently contributes to unfavorable clinical outcomes in patients with various cardiovascular diseases.

METHODS

We retrospectively analyzed consecutive patients with severe aortic stenosis to investigate the association between PVAT attenuation measured before transcatheter aortic valve replacement (TAVR) and subsequent clinical outcomes. PVAT attenuation was measured using computed tomography angiography images around the aortic valve. The primary outcome was defined as major adverse cardiovascular events (MACE), a composite of all-cause death, stroke, and heart failure rehospitalization.

RESULTS

MACE was observed in 23.6% of 233 patients during a median follow-up of 2.2 years. The MACE group had significantly higher PVAT attenuation than the non-MACE group (-74.0±9.8 Hounsfield unit [HU] versus -78.9±9.2 HU, P=0.001). In the Cox regression model, higher PVAT attenuation was independently associated with MACE (hazard ratio: 1.52 [95% CI: 1.13-2.04], P=0.006). Incorporating PVAT attenuation into established prognostic factors following TAVR improved the predictive and reclassification performance of MACE risk.

CONCLUSIONS

Elevated PVAT attenuation around the aortic valve was associated with MACE in patients undergoing TAVR. Measuring PVAT attenuation before TAVR can help identify patients at higher risk of developing heart failure or cardiovascular death after TAVR, thereby aiding in treatment strategy decisions.

REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique Identifier: UMIN000057107.

Для цитирования: Okamoto Hiroya, Toba Takayoshi, Sugizaki Yoichiro, Kawamori Hiroyuki, Hiromasa Takashi, Fujimoto Daichi, Izawa Yu, Osumi Yuto, Yamamoto Tetsuya, Iwane Seigo, Naniwa Shota, Yoshida Chiaki, Sakamoto Yuki, Matsuhama Koshi, Fukuishi Yuta, Tsunamoto Hiroshi, Higuchi Kotaro, Watanabe Nobuhiro, Takata Ken, Iida Keisuke, Kitagawa Tatsuya, Masuda Mayuka, Yoshida Shotaro, Hashimura Hiromi, Murakami Takamichi, Otake Hiromasa. Impact of Perivascular Adipose Tissue Attenuation Around the Aortic Valve on Clinical Outcomes After Transcatheter Aortic Valve Replacement.. Journal of the American Heart Association. 2026. DOI: 10.1161/jaha.125.046324.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.